One-Time radiation boost during breast surgery shows promise in Early-Stage cancer trial
NCT ID NCT02927912
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a single dose of radiation directly to the tumor site during breast-conserving surgery (lumpectomy) and before reconstruction is safe and effective for women with early-stage breast cancer. About 108 participants with stage I-II breast cancer will receive this targeted radiation boost. The goal is to kill remaining tumor cells while potentially improving cosmetic results and reducing the need for additional treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IA BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Centre Hospitalier de I'Universite de Montreal
Québec, Montreal, H2X0C1, Canada
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
University Hospitals
Cleveland, Ohio, 44106, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Triple threat: new combo shows promise against tough breast cancer
- Could adding carboplatin to chemo keep triple-negative breast cancer away?
- Blood test catches cancer early: new drug aims to stop spread
- Immune booster before chemo shows promise for tough breast cancer
- Could a one-week radiation zap be just as good as three weeks for early breast cancer?
- New chemo combo aims to shrink aggressive breast cancer before surgery